Buy Bliss GVS Pharma Ltd, target Rs 220.0 : Kunal Bothra

Independent Analyst, Kunal Bothra has a buy call on Bliss GVS Pharma Ltd. with a target price of Rs 220.0 .The current market price of Bliss GVS Pharma Ltd. is 195.3 Time period given by analyst is Intra Day when Bliss GVS Pharma Ltd. price can reach defined target. Kunal Bothra recommended to keep stoploss at Rs 180.0 .

Bliss GVS Pharma Ltd., incorporated in the year 1984, is a midcap company (having a market cap of ₹ 1866.44 Cr.) operating in Pharmaceuticals and health care sector.

Bliss GVS Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed ₹ 316.61 Cr to Sales Value (97.00 % of Total Sales), Export Incentives which contributed ₹ 6.69 Cr to Sales Value (2.05 % of Total Sales) and Health Care Products which contributed ₹ 3.09 Cr to Sales Value (0.94 % of Total Sales)for the year ending 31-Mar-2016.

For the quarter ended 31-03-2017, the company has reported a Consolidated sales of ₹ 258.30 Cr., up 13.76% from last quarter Sales of ₹ 227.05 Cr. and up 83.96% from last year same quarter Sales of ₹ 140.41 Cr. Company has reported net profit after tax of ₹ 46.38 Cr. in latest quarter. The company’s CEO is Mr.S N Kamath. It's Board of Directors include Ms.Aditi Bhatt, Dr.Vibha Gagan Sharma, Mr.Gautam R Ashra, Mr.Mayank S Mehta, Mr.S N Kamath, Mr.S R Vaidya, Mr.Santosh Parab, Mr.Vipul B Thakkar, Mrs.Shruti Vishal Rao, Ms.Aditi Bhatt. Company has its registered office at 102, Hyde Park, , Sakivihar Road,, Andheri - East, Mumbai, 400072, Maharashtra. Company has B K Khare & Co. as its auditors. As on 31-03-2017, the company has a total of 103,146,672 shares outstanding.